Pharos iBio Co., Ltd. (KOSDAQ:388870)
South Korea · Delayed Price · Currency is KRW 8,510.00
-160.00 (-1.85%)
At close: Feb 13, 2026
Pharos iBio Market Cap
Pharos iBio has a market cap or net worth of 110.17 billion as of February 13, 2026. Its market cap has increased by 4.55% in one year.
Market Cap
110.17B
Enterprise Value
101.53B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
8,510.00
Market Cap Chart
Since July 27, 2023, Pharos iBio's market cap has decreased from 112.78B to 110.17B, a decrease of -2.32%. That is a compound annual growth rate of -0.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 110.17B | -9.37% |
| Dec 30, 2025 | 121.56B | 24.04% |
| Dec 30, 2024 | 98.00B | -48.85% |
| Dec 28, 2023 | 191.59B | 69.87% |
| Jul 27, 2023 | 112.78B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| OPTUS Pharmaceutical | 141.17B |
| KOREA PHARMA | 138.73B |
| Samik Pharmaceutical Company LTD. | 135.74B |
| HYUNDAI BIOLAND | 132.90B |
| WITHUS PHARMACEUTICAL Co.,LTD. | 113.27B |
| Ahn-Gook Pharmaceutical | 100.24B |
| H.PIO | 99.27B |
| Sam-A Pharm. | 98.51B |